166 related articles for article (PubMed ID: 18029833)
1. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma.
Schwarz JK; Siegel BA; Dehdashti F; Grigsby PW
JAMA; 2007 Nov; 298(19):2289-95. PubMed ID: 18029833
[TBL] [Abstract][Full Text] [Related]
2. Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome.
Grigsby PW; Siegel BA; Dehdashti F; Rader J; Zoberi I
J Clin Oncol; 2004 Jun; 22(11):2167-71. PubMed ID: 15169804
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography-computed tomography for response evaluation in recurrent carcinoma cervix: does metabolic response predict survival?
Dhull VS; Sharma P; Sharma DN; Maharjan S; Suman Kc S; Patel C; Bal C; Kumar R
Int J Gynecol Cancer; 2014 Feb; 24(2):312-20. PubMed ID: 24407578
[TBL] [Abstract][Full Text] [Related]
4. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis.
Kidd EA; Siegel BA; Dehdashti F; Rader JS; Mutch DG; Powell MA; Grigsby PW
J Clin Oncol; 2010 Apr; 28(12):2108-13. PubMed ID: 20308664
[TBL] [Abstract][Full Text] [Related]
5. Roles of posttherapy
Liu FY; Su TP; Wang CC; Chao A; Chou HH; Chang YC; Yen TC; Lai CH
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1197-1204. PubMed ID: 29470614
[TBL] [Abstract][Full Text] [Related]
6. Metabolic response on post-therapy FDG-PET predicts patterns of failure after radiotherapy for cervical cancer.
Schwarz JK; Siegel BA; Dehdashti F; Grigsby PW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):185-90. PubMed ID: 22014958
[TBL] [Abstract][Full Text] [Related]
7. 18F-fluoro-2-deoxy-D-glucose positron emission tomography standard uptake value ratio as an indicator of cervical cancer chemoradiation therapeutic response.
Kunos C; Radivoyevitch T; Abdul-Karim FW; Faulhaber P
Int J Gynecol Cancer; 2011 Aug; 21(6):1117-23. PubMed ID: 21792015
[TBL] [Abstract][Full Text] [Related]
8. Impact of post-therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancer.
Siva S; Herschtal A; Thomas JM; Bernshaw DM; Gill S; Hicks RJ; Narayan K
Cancer; 2011 Sep; 117(17):3981-8. PubMed ID: 21365626
[TBL] [Abstract][Full Text] [Related]
9. Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer.
Schwarz JK; Siegel BA; Dehdashti F; Myerson RJ; Fleshman JW; Grigsby PW
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):180-6. PubMed ID: 17996387
[TBL] [Abstract][Full Text] [Related]
10. 18-F-fluorodeoxyglucose-positron emission tomography evaluation of early metabolic response during radiation therapy for cervical cancer.
Schwarz JK; Lin LL; Siegel BA; Miller TR; Grigsby PW
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1502-7. PubMed ID: 18538498
[TBL] [Abstract][Full Text] [Related]
11. Defining the priority of using 18F-FDG PET for recurrent cervical cancer.
Yen TC; See LC; Chang TC; Huang KG; Ng KK; Tang SG; Chang YC; Hsueh S; Tsai CS; Hong JH; Lin CT; Chao A; Ma SY; Lin WJ; Fu YK; Fan CC; Lai CH
J Nucl Med; 2004 Oct; 45(10):1632-9. PubMed ID: 15471826
[TBL] [Abstract][Full Text] [Related]
12. ¹⁸F-FDG PET/CT following chemoradiation of uterine cervix cancer provides powerful prognostic stratification independent of HPV status: a prospective cohort of 105 women with mature survival data.
Siva S; Deb S; Young RJ; Hicks RJ; Callahan J; Bressel M; Mileshkin L; Rischin D; Bernshaw D; Narayan K
Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1825-32. PubMed ID: 26173619
[TBL] [Abstract][Full Text] [Related]
13. F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy.
Xue F; Lin LL; Dehdashti F; Miller TR; Siegel BA; Grigsby PW
Gynecol Oncol; 2006 Apr; 101(1):147-51. PubMed ID: 16263155
[TBL] [Abstract][Full Text] [Related]
14. Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer.
Brooks RA; Rader JS; Dehdashti F; Mutch DG; Powell MA; Thaker PH; Siegel BA; Grigsby PW
Gynecol Oncol; 2009 Jan; 112(1):104-9. PubMed ID: 18929403
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: from diagnosis to prognosis.
Chung HH; Kim SK; Kim TH; Lee S; Kang KW; Kim JY; Park SY
Gynecol Oncol; 2006 Oct; 103(1):165-70. PubMed ID: 16574205
[TBL] [Abstract][Full Text] [Related]
16. Posttherapy surveillance monitoring of cervical cancer by FDG-PET.
Grigsby PW; Siegel BA; Dehdashti F; Mutch DG
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):907-13. PubMed ID: 12605968
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of post-treatment ¹⁸F-fluorodeoxyglucose positron emission tomography in uterine cervical cancer patients treated with radiotherapy: a systematic review and meta-analysis.
Kim YJ; Han S; Kim YS; Nam JH
J Gynecol Oncol; 2019 Sep; 30(5):e66. PubMed ID: 31328452
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose-positron emission tomography simulation in patients with locally advanced cervical cancer.
Kidd EA; Siegel BA; Dehdashti F; Rader JS; Mutic S; Mutch DG; Powell MA; Grigsby PW
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1085-91. PubMed ID: 19880262
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral metabolic heterogeneity of cervical cancer.
Kidd EA; Grigsby PW
Clin Cancer Res; 2008 Aug; 14(16):5236-41. PubMed ID: 18698042
[TBL] [Abstract][Full Text] [Related]
20. PET/CT imaging to guide cervical cancer therapy.
Grigsby PW
Future Oncol; 2009 Sep; 5(7):953-8. PubMed ID: 19792965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]